Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

BACKGROUND: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-based (PI/r) dual therapy (DT). METHODS: Observational, retrospective switch study in patients successfully treated with triple drugs regimen. Patients switched to PI/r based DT [darunavir (DRV/r), lopina...

Descripción completa

Detalles Bibliográficos
Autores principales: Latini, Alessandra, Fabbiani, Massimiliano, Borghi, Vanni, Sterrantino, Gaetana, Giannetti, Alberto, Lorenzini, Patrizia, Loiacono, Laura, Ammassari, Adriana, Bellagamba, Rita, Colafigli, Manuela, D’Ettorre, Gabriella, Di Giambenedetto, Simona, Antinori, Andrea, Zaccarelli, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982404/
https://www.ncbi.nlm.nih.gov/pubmed/27515949
http://dx.doi.org/10.1186/s12879-016-1703-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982404/
https://www.ncbi.nlm.nih.gov/pubmed/27515949
http://dx.doi.org/10.1186/s12879-016-1703-z

Ejemplares similares